Please login to the form below

empagliflozin

This page shows the latest empagliflozin news and features for those working in and with pharma, biotech and healthcare.

Lilly trumpets Trulicity heart data in face-off with Novo Nordisk

Boehringer Ingelheim and Lilly’s SGLT2 inhibitor Jardiance (empagliflozin) was the first drug approved by the FDA as being able to reduce the risk of cardiovascular death in patients with type

Latest news

J&J’s Invokana aces diabetic kidney disease trial, setting up filings

risk of lower-limb amputation in diabetics, putting it at a disadvantage compared to rival SGLT2 drugs such as Eli Lilly and Boehringer Ingelheim's Jardiance (empagliflozin) and AstraZeneca’s Farxiga
J&J says real-world data finds no amputation risk for Invokana

s Jardiance (empagliflozin), but was also linked to an increased risk of lower-limb amputation.
Real-world data finds patients feel better on Entresto, says Novartis

s Jardiance (empagliflozin), as around a third of patients with heart failure also have diabetes.
FDA’s year-end approvals take annual tally to 46

established drugs Johnson &Johnson’s first-to-market blockbuster Invokana (canagliflozin) - which brought in more than $1.2bn last year - fast-gaining rival Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim
Lilly mulls divestment of its animal health operations

to surging sales of diabetes drugs Trulicity (dulaglutide) and Jardiance (empagliflozin) and a near five-fold increase for psoriasis drug Taltz (ixekizumab).

More from news
Approximately 15 fully matching, plus 65 partially matching documents found.

Latest Intelligence

Market dynamics, marketing and analytics

The remaining two SGLT2s are growing faster than the market, with Jardiance (empagliflozin) leading the market in terms of growth.
Interview: Christopher Boulton, AstraZeneca

s empagliflozin, but AstraZeneca's strength is the wide range of oral diabetes products it has to offer, says Boulton. “

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

New Business Director - PR: Competitive Salary and benefits

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Production Manager – Healthcare Communications: DOE

Senior Medical Writer (Remote Working): Competitive Salary Offered

Project / Account Manager (Medical Education): Salary TBC

Associate Medical Director: Highly Competitive

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Senior Account Executive, London, Medical Communications: Excellent package

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Account Director: Excellent benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Director, Market Access / HEOR - North-West: Negotiable

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Associate Director: £75, 000-90, 000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Medical Writer: Great salary and benefits

Medical/ Scientific Director: Salary TBC

Account Manager / Account Director: Competative

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Account Director development role to Business Director, H...: Excellent package

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Subscribe to our email news alerts

PMHub

Add my company

Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...